DrKids Himasal Natural Nasal Saline Solution, packaged in Pre-measured Singe-Use Vials a) 0.5 m...
FDA Drug Recall #D-0133-2020 — Class II — September 23, 2019
Recall Summary
| Recall Number | D-0133-2020 |
| Classification | Class II — Moderate risk |
| Date Initiated | September 23, 2019 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Unipharma, Llc. |
| Location | Tamarac, FL |
| Product Type | Drugs |
| Quantity | 456 cartons |
Product Description
DrKids Himasal Natural Nasal Saline Solution, packaged in Pre-measured Singe-Use Vials a) 0.5 mL Each (20 count) UPC 37030244608; b) 1.5 mL Each (20 count) UPC 370302446098, Manufactured in USA by: UNIPHARMA, LLC Tamarac, FL 33321
Reason for Recall
CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.
Distribution Pattern
U.S.A. Nationwide
Lot / Code Information
Lot: 80003 Exp. 01/31/20; 70003 Exp. 10/31/19; 70005 Exp. 11/30/19; 70006 Exp. 11/30/19
Other Recalls from Unipharma, Llc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0132-2020 | Class II | DrKids Children's Natural Cough Syrup English I... | Sep 23, 2019 |
| D-1632-2019 | Class II | DrKids Children's Allergy Relief Diphenhydramin... | Jul 15, 2019 |
| D-1631-2019 | Class II | CVS Health Children's Allergy Relief Liquid Med... | Jul 15, 2019 |
| D-1633-2019 | Class II | CVS Health Children's Nasal Saline Drops with H... | Jul 15, 2019 |
| D-1306-2019 | Class II | CVS Health Children's Cough & Chest Congestion ... | May 2, 2019 |
Frequently Asked Questions
cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.